Mark C. McKenna
2021
In 2021, Mark C. McKenna earned a total compensation of $12M as Chairman of the Board, President and Chief Executive Officer at Prometheus Biosciences, a 314% increase compared to previous year.
Compensation breakdown
| Bonus | $1,000,000 |
|---|---|
| Non-Equity Incentive Plan | $632,500 |
| Option Awards | $9,813,366 |
| Salary | $565,522 |
| Other | $17,645 |
| Total | $12,029,033 |
McKenna received $9.8M in option awards, accounting for 82% of the total pay in 2021.
McKenna also received $1M in bonus, $632.5K in non-equity incentive plan, $565.5K in salary and $17.6K in other compensation.
Rankings
In 2021, Mark C. McKenna's compensation ranked 771st out of 12,406 executives tracked by ExecPay. In other words, McKenna earned more than 93.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 771 out of 12,406 | 94th |
Division Manufacturing | 250 out of 5,494 | 95th |
Major group Chemicals And Allied Products | 81 out of 2,369 | 97th |
Industry group Drugs | 69 out of 2,090 | 97th |
Industry Pharmaceutical Preparations | 43 out of 1,537 | 97th |
Source: SEC filing on April 1, 2022.
McKenna's colleagues
We found three more compensation records of executives who worked with Mark C. McKenna at Prometheus Biosciences in 2021.